Navigation Links
Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services
Date:12/1/2009

ect management, worldwide site and equipment logistics, 24/7 customer support and regulatory data submission. iCardiac’s analysis services provide drug developers with more precise and cost-effective methods for ECG interval measurements, including Highly Automated QT, which is the market leading solution for automated evaluation of QT intervals for regulatory submissions. In addition, iCardiac provides Beyond QTsm, a suite of advanced ECG-based cardiac safety markers that have been accepted and used as a secondary end-point in regulatory approvals, and which delivers a more accurate assessment of the cardiac safety profile of drugs in development. iCardiac’s COMPAS technology has been used for over a decade in cardiac clinical trials conducted for and by leading large and medium sized pharmaceutical, biotechnology and medical device companies. For more information, visit: www.icardiac.com.

###

Read the full story at http://www.prweb.com/releases/top_five_pharma/icardiac/prweb3272134.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. The MedZilla Report for August 2009 -- Health Care Grows Another 28,000 While Hospitals And Insurers Feel Painful Pinch
2. The first DFG research centers to be funded for another 4 years
3. GeneGo Renews Its Agreement With Bayer Schering Pharma AG for Another Three Years
4. OmniComm Systems, Inc. Is Fueled by Another Strong Quarter Delivering Electronic Data Capture (EDC) Solutions & Services
5. Cephalon Reports Another Strong Quarter
6. DSM and Crucell Announce Another Key Achievement for PER.C6(R) Technology; Scale Up of High-Titer Fed-Batch Process to 250 Liters
7. Diverse Coalition of Purchasers Respond to BIO CEO Fly-In: There is Another Side to The Story
8. Another industry first enabled by Benchmark Biolabs - Peros oral delivery platform and vaccine facility licensed by the USDA
9. 2007 Another Record Year in Terms of Sales and Earnings for Gerresheimer
10. Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
11. Signalife Receives Another $3.3 Million Sales Orders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... N.J. , June 1, 2015  Novartis ... clinical study of CTL019, an investigational chimeric antigen ... potential in the treatment of specific types of ... conducted by the University of Pennsylvania,s Perelman School ... refractory (r/r) diffuse large B-cell lymphoma (DLBCL) and ...
(Date:6/1/2015)... June 1, 2015  Fennec Pharmaceuticals, Inc. (TSX: ... interim results from a poster presented today entitled, ... randomised phase III trial of the efficacy of ... receiving cisplatin (Cis) monotherapy for standard risk hepatoblastoma ... Society of Clinical Oncology (ASCO) 2015 Annual Meeting ...
(Date:6/1/2015)... , June 1, 2015 /CNW/ - Resverlogix Corp. ... on RVX-208 was presented at the ERA-EDTA Congress in ... entitled: "Effects of RVX-208, a First-in-Class Epigenetic BET-Inhibitor, on ... CVD, and Chronic Kidney Disease (CKD); a Post-hoc Analysis ... Trials." Dr. Kam Kalantar-Zadeh , ...
(Date:6/1/2015)... June 1, 2015  Albany Molecular Research ... that it has signed a collaborative agreement ... their structure-based drug discovery services to global ... the three-year agreement, AMRI gains access to ... capabilities. HarkerBIO,s customers will be able to ...
Breaking Biology Technology:Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 2Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 3Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 4Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 5Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 6Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 2Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 3Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 4Resverlogix Presents New Data at 52nd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA) 2Resverlogix Presents New Data at 52nd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA) 3Resverlogix Presents New Data at 52nd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA) 4AMRI and HarkerBIO Ink Collaborative Agreement in Buffalo, N.Y. 2AMRI and HarkerBIO Ink Collaborative Agreement in Buffalo, N.Y. 3
... , ... , , , , ... an siRNA sequence,for a target gene, which are of,high importance ... crucial.,An efficient method to optimize,transfection and gene silencing,is critical for ...
... , , ... , , , This ... LabChip kit can be used to detect cell surface,and intracellular protein ... CD4 staining on CCRF-CEM cells and intracellular,glucocorticoid receptor (GR) staining of ...
... , , ... , , , , ... protein,expression in samples of low cell numbers , , , ... working,with primary cells have, for example,limited availability, quantity,and lifespan. Using the ...
Cached Biology Technology:Confirming gene silencing,mechanism by pGFP/GFP22 ,siRNA co-transfection 2Confirming gene silencing,mechanism by pGFP/GFP22 ,siRNA co-transfection 3Confirming gene silencing,mechanism by pGFP/GFP22 ,siRNA co-transfection 4Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 2Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 3Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 4Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 5Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 6Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 7Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 8Flow cytometric analysis of human,primary cells using the Agilent 2100,bioanalyzer and on-chip staining 2Flow cytometric analysis of human,primary cells using the Agilent 2100,bioanalyzer and on-chip staining 3
(Date:5/22/2015)... 22, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... be ending its promotional pricing and making the Wocket generally ... Laurence Savin , Head of Marketing said, "We,ve extended the ... the end of May. To get your wocket at this ... open the store on June 1, you,ll receive a unique ...
(Date:5/20/2015)... , May 20, 2015 ... ) has announced the addition of ... Global Iris Recognition Market"  report to ... ,This research service analyses trends in ... government and commercial sectors, globally. Despite ...
(Date:5/19/2015)... 2015 Research and ... of the  "Genetic Testing Market Outlook 2018" ... , ,A recent report, Genetic Testing Market ... the current and future genetic testing market. ... working principles and types are covered in ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2
... by Mother Nature, scientists are reporting development of a protective ... in a dormant condition for long periods despite intense heat, ... Journal of the American Chemical Society , they liken the ... anthrax and certain other bacterial cells, making those microbes difficult ...
... years of futile attempts, new research from the Monell Center ... culture for at least seven months. The findings provide scientists ... of taste and how it functions in health and disease. ... treat taste loss or impairment due to infection, radiation, chemotherapy ...
... ORLANDO, Fla. Breast cancer survivors with poor physical ... including recurrence and death, according to the results of an ... held April 2-6. Survivors of breast cancer who ... experience either a recurrence of their cancer or a new ...
Cached Biology News:Human taste cells regenerate in a dish 2Physical health scores predict breast cancer outcomes 2
... Nonreversible lids with condensation ... Individual alphanumerical codes for ... for ease in stacking,• ... attachment,• Sterilized by gamma ...
... Cyclin D2 is a G1 cyclin required ... candidate for a proto-oncogene. cyclin D2 ... and/or cdk6. Species Reactivity: Human, Mouse, ... DCS-3.1 MAb is particularly well suited for ...
... The 2/3D Waver Shaker combines shaking and rocking ... a 330 x 330 mm stainless steel or ... incubator and cold room operation. The platform angle ... for a vigorous with action and rotation speed ...
... The PROTEAN II xi 2-D system runs both ... first-dimension IEF tube gels can be separated in a ... onto the cooling core in much the same manner ... are running, the second-dimension slab gels may be cast ...
Biology Products: